Corporate Directors to Convene in Geneva for World's First-Ever Global Cyber Forum
NACD to Host Global Boardroom and Cybersecurity Leaders to Elevate Cyber-Risk Oversight Practices
WASHINGTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- The National Association of Corporate Directors (NACD), the authority on boardroom practices representing more than 18,000 corporate board members, today announced its 2018 Global Cyber Forum, which will be held April 17-18 in Geneva, Switzerland. This event recognizes the global nature of cyber threats and gives international scope to NACD's efforts to drive board members' greater understanding of, and role in, cybersecurity oversight.
An elite group of nonexecutive directors (NEDs) of multinational corporations, C-suite and managing-director-level executives, cybersecurity experts, global cybersecurity policy and law enforcement officials, and other thought leaders will attend the forum. Participants will examine leading board-level cyber-risk oversight practices and explore key themes that include cross-border law enforcement, the shifting global regulatory landscape, the impact of emerging technologies on cybersecurity, and leading practices in cyber hygiene. The forum will engage attendees in a cyberbreach simulation for interactive learning.
"As new threats arise amid increased global integration and connectivity, corporate boards need to be well-versed in their companies' vulnerabilities in order to be prepared in the event of a cyberbreach," said NACD CEO Peter Gleason. "Our primary goal is to provide NEDs and company leaders with practical information they can take back to the boardroom."
- The Right Honorable Baroness Pauline Neville-Jones, DCMG; former top British diplomat and Advisor to Prime Minister David Cameron; Chair of the Bank of England's Cybersecurity Panel; Senior Advisor to Ridge-Schmidt Cyber; and Council Member of the UK Research Council
- Olga Botero, Director and Chair of the Technology and Cyber Security Committee for EVERTEC Inc. and Former Chief Information Officer of Grupo Bancolombia
- Greg Bell, Principal, Advisory Services, KPMG LLP
- Anastassia Lauterbach, Director and Chair of the Technology and Innovation Committee for Dun & Bradstreet
- Sara Grootwassink Lewis, Audit Committee Chair, Sun Life Financial, Weyerhaeuser Co., and PS Business Parks; Director, Leadership Board of the U.S. Chamber of Commerce Center for Capital Markets Competitiveness; and Trustee, Brookings Institution
- Richard Spearman, Group Corporate Security Director, Vodafone Group PLC
- Akhilesh Tuteja, Global Practice Colead, India Region, KPMG LLP
- Jeff Brown, Vice President and Chief Information Security Officer, Raytheon Co.
- Maya Bundt, Head, Cyber and Digital Solutions, Swiss Reinsurance Co. Ltd.
- Shelley Leibowitz, Director of E*TRADE Financial and Former Group Chief Information Officer for the World Bank
- Larry Clinton, President and CEO, Internet Security Alliance
- Dani Michaux, Asia Regional Leader, KPMG LLP
- Major General Koen Gijsbers (Ret.), Senior Advisor, Network Centric Industry Operations Industry Consortium; Former General Manager, NATO Communications and Information Agency; and Former CIO, Netherlands Ministry of Defence
- John Hermans, EMA Regional Leader, KPMG LLP
- William McCracken, Director of MDU Resources Group Inc. and NACD, and Former Chair and CEO of CA Technologies
NACD is proud to partner with KPMG for this event. Other partners include the Global Network of Director Institutes (GNDI), the Internet Security Alliance (ISA), and Ridge Global.
For more information about the forum, visit www.NACDonline.org/CyberForum.
The National Association of Corporate Directors (NACD) empowers more than 18,000 directors to lead with confidence in the boardroom. As the recognized authority on leading boardroom practices, NACD helps boards strengthen investor trust and public confidence by ensuring that today's directors are well prepared for tomorrow's challenges. World-class boards join NACD to elevate performance, gain foresight, and instill confidence. Fostering collaboration among directors, investors, and corporate governance stakeholders, NACD has been setting the standard for responsible board leadership for 40 years. To learn more about NACD, visit www.NACDonline.org.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: National Association of Corporate Directors via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Partnership Between Zaiput Flow Technologies and ThalesNano Set to Improve Process Intensification18.10.2018 15:21 | Pressemelding
BUDAPEST, Hungary and WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zaiput Flow Technologies, a global leader in separation, and ThalesNano, the world leader in bench-top flow chemistry reactors, recently signed a distribution agreement and entered into a technology partnership that exploits the benefits of their combined technologies. Under the distribution Zaiput liquid-liquid phase separators and back pressure regulators are available via ThalesNano in Europe and a number of other countries on a non-exclusive basis, either separately or as part of a bundled offering with ThalesNano’s own microflow reactors. Within the framework of the technology partnership the companies will collaborate to promote adoption of the combined use of their technologies. “We are very excited to work with ThalesNano to offer better-integrated flow chemistry systems to our customers and streamline the work of both novice and experienced users in the flow chemistry space,” said Zaiput CEO, Dr. Andrea Ad
Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer18.10.2018 14:03 | Pressemelding
NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer. As a result, former Chief Medical Officer Juan Ruiz, M.D., Ph.D. will assume the role of Head of European Medical Affairs. The Company also announced the appointment of Neena Patil, J.D. as General Counsel and Corporate Secretary. Both Dr. Siffert and Ms. Patil report to Chief Executive Officer, Carsten Thiel, Ph.D. “I am very pleased to welcome João and Neena to Abeona, and confident in their abilities to make important contributions to the future growth of our company,” said Dr. Thiel. “João has an ideal blend of clinical, scientific, and regulatory experience to reference as we look to advance our clinical and pre-clinical can
Meltwater and Dow Jones Announce Global Partnership to Provide Premium Content18.10.2018 14:00 | Pressemelding
SAN FRANCISCO and NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Meltwater, a global leader in media intelligence, today announces the launch of a partnership with Dow Jones, a global provider of news and business information, to provide premium licensed content from Dow Jones Factiva into the Meltwater Media Intelligence platform. This partnership will give Meltwater’s PR and communications clients the ability to monitor and analyze premium licensed content across thousands of Factiva news sources globally, including: The Wall Street Journal, America’s largest newspaper by paid circulation; Barron’s; MarketWatch; and Dow Jones Newswires. “Meltwater provides our clients with the most comprehensive content network globally, across news, social media and broadcast media. This new Dow Jones partnership will further strengthen our leadership position and allow our clients to access licensed content from some of the most highly-respected news outlets in the world. We’re excited about this part
Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting18.10.2018 13:30 | Pressemelding
EMBARGOED FOR DISTRIBUTION Please note CTAD embargo policy: All materials submitted to CTAD are embargoed for publication and broadcast until the officially scheduled date and time of presentation, symposia or poster session. Data to be presented across the Alzheimer’s disease clinical development portfolio, including aducanumab, BAN2401 and elenbecestat CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) announced it will present data from its Alzheimer’s disease (AD) clinical development portfolio at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) annual meeting in Barcelona, Spain (October 24-27). The data being presented are part of Biogen’s ongoing research programs targeting possible causes of the disease through multiple modalities. “We are excited to engage with the scientific community at CTAD, to share learnings from our Alzheimer’s disease clinical research and to learn from the work of our colleagues around the world. We have hopes that our
SEMAFO Provides Notice of Third Quarter 2018 Results Release and Conference Call 18.10.2018 13:30 | Pressemelding
MONTREAL, Oct. 18, 2018 (GLOBE NEWSWIRE) -- SEMAFO (TSX, OMX: SMF) invites you to participate in a conference call on November 7, 2018 at 10:00 AM EST with senior management during which they will review the Corporation's third quarter 2018 financial and operational results. SEMAFO's financial statements and management's discussion and analysis for the third quarter 2018 will be released on November 6 after market hours and will be available in the “Investor Relations” section of the Corporation's website at www.semafo.com , and on the Canadian Securities Administrators' website at www.sedar.com . A live audio webcast of the conference call will be accessible for a period of 30 days through SEMAFO’s website at www.semafo.com . Tel. local & overseas: +1 (647) 788 4922 Tel. North America: 1 (877) 223 4471 Webcast: www.semafo.com Replay overseas: +1 (416) 621 4642 Replay N. America: 1 (800) 585 8367 Replay pass code: 2823689 Expiration: December 7, 2018 About SEMAFO SEMAFO is a Canadian-b
Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA18.10.2018 13:30 | Pressemelding
TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- (CSE: BIO) – Biome Grow (“Biome” or the “Company”) (CSE:BIO) is pleased to announce that the Company’s common shares have been listed on the Frankfurt Stock Exchange under the trading symbol “6OTA”. The Company’s common shares continue to be listed on the Canadian Securities Exchange (“CSE”) under the trading symbol “BIO”. “Biome is developing its production base in Canada with an eye to becoming a leader in the international medical cannabis market. Listing on the Frankfurt Stock Exchange will give Biome increased access to European and other international investors and positions Biome well for international growth and development opportunities,” said CEO Khurram Malik. The Frankfurt Stock Exchange is one of the world’s largest trading centres for securities. With a share in turnover of around 90 per cent, it is the largest of Germany’s seven stock exchanges and it is an international trading centre, which is reflected in the structure of its
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom